AR121273A2
(en )
2022-05-04
ENZYMATIC INHIBITORS FOR USE IN MEDICINE AND PHARMACEUTICAL COMPOSITION THAT COMPRISES THEM
MX2020009461A
(en )
2021-02-17
Anti-pvrig antibodies and methods of use.
CL2018000595A1
(en )
2018-12-28
Anti-PD1 antibodies and methods of use
CU20180059A7
(en )
2018-10-04
INHIBITING COMPOUNDS OF THE QUINASA DE UNIÓN A TANK
PL3510033T3
(en )
2022-03-07
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF TOLL-LIKE ENDOSOMAL RECEPTORS
CL2016003261A1
(en )
2017-10-06
Formulation comprising a gemcitabine prodrug
CL2015002239A1
(en )
2016-02-05
Modulators of methyl modifying enzymes, compositions comprising them and their uses
CR20150549A
(en )
2016-01-04
HETEROCYCLIC COMPOUNDS AND THEIR USES
CL2018001722A1
(en )
2018-10-12
New anti-mfi2 antibodies and methods of use (divisional application 201700506)
MX2022000053A
(en )
2022-03-11
SESTRIN-GATOR2 INTERACTION MODULATORS AND THEIR USES.
CL2017000716A1
(en )
2017-12-15
Rorc2 pyrrolopyridine modulators substituted with methyl and trifluoromethyl and methods of use thereof
MX382747B
(en )
2025-03-11
OPTIONALLY CONFENSED HETEROCYCLYN SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOIMMUNE DISEASES.
MX2019005322A
(en )
2019-10-14
COATING COMPOSITIONS AND METHODS OF USE OF THEM.
PL3405178T3
(en )
2025-11-12
PREPARATIONS/COMPOSITIONS CONTAINING BTK INHIBITOR
MX2019010643A
(en )
2019-10-17
Forms and compositions of a mk2 inhibitor.
CO2017001389A2
(en )
2017-05-10
Azetidinyloxyphenylpyrrolidine compounds
CR20180089A
(en )
2018-02-27
USEFUL COMPOUNDS TO INHIBIT ROR-GAMMA-T
SV2016005293A
(en )
2018-04-30
AMIDO-REPLACED AZOL COMPOUNDS AS INHIBITORS OF TNKS1 AND / OR TNKS2
DOP2020000104A
(en )
2020-08-31
METHODS OF USE AND COMPOSITIONS CONTAINING DULAGLUTIDA
TWD192672S
(en )
2018-09-01
Cartridge bladder
CO2018011420A2
(en )
2019-02-08
Liquid phosphaplatin formulations
NI201800016A
(en )
2019-02-08
HERBICIDE COMPOSITION AND PROCESS TO PREPARE IT
ITUA20161994A1
(en )
2017-09-24
USE OF DDX3 INHIBITORS AS ANTI-HYPER-PERFORMANCE AGENTS
MX2017011904A
(en )
2018-11-09
COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND AFFECTIONS RELATED TO FIBROSIS.
AR105950A1
(en )
2017-11-29
A FORMULATION READY TO USE FOR INJECTION OF VINCRISTINE SULFATE LIPOSOMES